Betamethasone Valerate
Sponsors
Arctic Bioscience AS, GlaxoSmithKline, ACO Hud Nordic AB, TetraLogic Pharmaceuticals, Ziauddin University
Conditions
Allergic Contact DermatitisAtopic EczemaHand EczemaOral Submucous FibrosisParonychiaPlaque Type PsoriasisPsoriasisSkin Inflammation
Phase 1
Phase 2
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
RecruitingNCT05535738
Start: 2022-11-15End: 2027-12-31Target: 45Updated: 2025-11-14
A phase 2B, multicenter, randomized, double-blind, placebo-controlled, dose-finding, efficacy and safety study of HRO350 in subjects with mild-to-moderate psoriasis (the ‘HeROPA’ study)
CompletedCTIS2022-501850-12-00
Start: 2023-03-15End: 2025-03-07Target: 376Updated: 2025-02-07
Phase 3
Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser
CompletedNCT00576238
Start: 2004-01-31End: 2008-02-29Updated: 2008-10-13
Comparative Effect of Nigella Sativa and Conventional Management for OSMF
CompletedNCT04476420
Start: 2021-02-11End: 2021-09-30Updated: 2022-03-15
Efficacy and Safety of Timolol for TKI Induced Paronychia
NCT06140186
Start: 2023-04-01End: 2024-03-31Target: 40Updated: 2023-12-20